Cargando…
Retracted: SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma
Autor principal: | Journal of Oncology |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356336/ https://www.ncbi.nlm.nih.gov/pubmed/37476559 http://dx.doi.org/10.1155/2023/9813986 |
Ejemplares similares
-
SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma
por: Huang, Rongxi, et al.
Publicado: (2022) -
Retracted: PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
por: Oncology, Journal of
Publicado: (2023) -
Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
por: Oncology, Journal of
Publicado: (2023) -
Retracted: TMEM60 Promotes the Proliferation and Migration and Inhibits the Apoptosis of Glioma through Modulating AKT Signaling
por: Oncology, Journal of
Publicado: (2023) -
Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
por: Oncology, Journal of
Publicado: (2023)